A round of job cuts at PACS developerAdvanced Video Products (AVP) has industry observers guessingat the intentions of parent E-Systems, which bought AVP in 1992(SCAN 11/4/92). About 13 AVP employees were let go, includingat least two high-ranking
A round of job cuts at PACS developerAdvanced Video Products (AVP) has industry observers guessingat the intentions of parent E-Systems, which bought AVP in 1992(SCAN 11/4/92). About 13 AVP employees were let go, includingat least two high-ranking executives and several recently hiredsalespeople. AVP had approximately 50 employees before the reductions.
AVP, of Westford, MA, has maintained a relatively low profilesince it was acquired by E-Systems. E-Systems put AVP's salesand marketing efforts on hold while it sorted out the company'smanagement team, bringing on Cemax veteran Gil Peterson to headthe company earlier this year (SCAN 2/2/94). AVP said it wouldmove rapidly in the PACS market after Peterson's appointment asvice president and general manager.
The staff reductions indicate that E-Systems may be again reevaluatingits approach to PACS. Tom Goliash, AVP founder and vice presidentof business development at E-Systems Medical, confirmed that thecompany was downsizing but said that it remained committed tothe medical market. He declined to elaborate further.
AVP is developing a Unix-based software platform, with theintention of unveiling a product at this year's Radiological Societyof North America meeting.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.